Jared Walsh, M.D.

Locations

Ambulatory Care Center at Strong Memorial Hospital
601 Elmwood Avenue, 5th Floor
Rochester, NY 14642

About Me

Jared Walsh is the Chief of General Medicine at the University of Rochester School of Medicine and Dentistry. A primary care internist and medical educator, his clinical and academic work focuses on integrated behavioral health and addiction medicine in primary care, quality improvement education, a...

Jared Walsh is the Chief of General Medicine at the University of Rochester School of Medicine and Dentistry. A primary care internist and medical educator, his clinical and academic work focuses on integrated behavioral health and addiction medicine in primary care, quality improvement education, and the role of emerging technologies in general internal medicine. Dr. Walsh completed his internal medicine residency at the University of Rochester, where he also served as Chief Resident before joining the faculty in the General Medicine Division. While on faculty, Dr. Walsh was selected as the Marshall Lichtman Dean’s Teaching Fellow. After four years, Dr Walsh transitioned to serve on the faculty at Rutgers New Jersey Medical School as Associate Program Director of the Internal Medicine Residency, Director of the Quality Improvement Program, Director of Integrated Behavioral Health and Addiction Medicine in Primary Care, and Director of the Academic Internal Medicine Practice. He returned to the University of Rochester in 2026. His clinical practice spans general primary care and integrated behavioral health and addiction medicine. He is a Fellow of the American College of Physicians and has received multiple teaching honors.

Certified Specialties

Internal Medicine - American Board of Internal Medicine

Faculty Appointments

Interim Associate Professor - Department of Medicine, General Medicine (SMD)

Interim Division Chief - Department of Medicine, General Medicine (SMD)

Credentials

Residency & Fellowship

Residency, Internal Medicine, University of Rochester Medical Center. 2015 - 2017

Internship, Internal Medicine, University of Rochester Medical Center. 2014 - 2015

Education

MD | Boston University School of Medicine. 2014

Awards

Marshall Lichtman Dean's Teaching Fellow. 2020 - 2022

Eli Shapiro Award.

David A. Haller Award For Compassionate Care of the Sick.

T. Franklin Williams Award.

Barbara Simms Primary Care Award for Interest and Commitment to the Field of Primary Care.

Lawrence E. Young Prize for Dedication to Patient Care and Teaching.

Research

Jared Walsh is the Chief of General Medicine at the University of Rochester School of Medicine and Dentistry. A primary care internist and medical educator, his clinical and academic work focuses on integrated behavioral health and addiction medicine in primary care, quality improvement education, a...

Jared Walsh is the Chief of General Medicine at the University of Rochester School of Medicine and Dentistry. A primary care internist and medical educator, his clinical and academic work focuses on integrated behavioral health and addiction medicine in primary care, quality improvement education, and the role of emerging technologies in general internal medicine. Dr. Walsh completed his internal medicine residency at the University of Rochester, where he also served as Chief Resident before joining the faculty in the General Medicine Division. While on faculty, Dr. Walsh was selected as the Marshall Lichtman Dean’s Teaching Fellow. After four years, Dr Walsh transitioned to serve on the faculty at Rutgers New Jersey Medical School as Associate Program Director of the Internal Medicine Residency, Director of the Quality Improvement Program, Director of Integrated Behavioral Health and Addiction Medicine in Primary Care, and Director of the Academic Internal Medicine Practice. He returned to the University of Rochester in 2026. His clinical practice spans general primary care and integrated behavioral health and addiction medicine. He is a Fellow of the American College of Physicians and has received multiple teaching honors.

Publications

Journal Articles

Socioeconomic disparities to come.

Malhotra R and Walsh J.

ACP Hospitalist. 2024; .

Ethnic Differences in Perceived Benefits and Barriers to HPV Vaccine Acceptance: A Qualitative Analysis of Young African American, Haitian, Caucasian, and Latino Men.

Joseph NP; Belizaire M; Porter CL; Walsh JP; Esang M; Goff G; et al.

Clin Pediatr. 2014; 53(2): 177-85.

Knowledge, attitudes, and beliefs regarding HPV vaccination: ethnic and cultural differences between African-American and Haitian immigrant women.

Joseph NP, Clark JA, Bauchner H, Walsh JP, Mercilus G, Figaro J, Bibbo C, Perkins RB

Women's health issues : official publication of the Jacobs Institute of Women's Health.. 2012 22 (6):e571-9. Epub 1900 01 01.

Analysis of peripheral immune activation in schizophrenia using quantitative reverse-transcription polymerase chain reaction (RT-PCR).

Freudenreich O, Brockman MA, Henderson DC, Evins AE, Fan X, Walsh JP, Goff DC

Psychiatry research.. 2010 April 30176 (2-3):99-102. Epub 02/04/2010.

Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial.

Freudenreich O, Henderson DC, Macklin EA, Evins AE, Fan X, Cather C, Walsh JP, Goff DC

The Journal of clinical psychiatry.. 2009 December 70 (12):1674-80. Epub 08/11/2009.

Extinction memory is impaired in schizophrenia.

Holt DJ, Lebron-Milad K, Milad MR, Rauch SL, Pitman RK, Orr SP, Cassidy BS, Walsh JP, Goff DC

Biological psychiatry.. 2009 March 1565 (6):455-63. Epub 11/04/2008.

A placebo-controlled study of sildenafil effects on cognition in schizophrenia.

Goff DC, Cather C, Freudenreich O, Henderson DC, Evins AE, Culhane MA, Walsh JP

Psychopharmacology.. 2009 January 202 (1-3):411-7. Epub 08/21/2008.

Modafinil for clozapine-treated schizophrenia patients. A double-blind, placebo-controlled trial.

Freudenreich O; Henderson DC; Macklin EA; Evins AE; Fan X; Cather C; et al.

Schizophr Bull. 2009; 35: 358-.

Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study.

Goff DC, Cather C, Gottlieb JD, Evins AE, Walsh J, Raeke L, Otto MW, Schoenfeld D, Green MF

Schizophrenia research.. 2008 December 106 (2-3):320-7. Epub 09/16/2008.

Risperidone augmentation for schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled trial.

Freudenreich O, Henderson DC, Walsh JP, Culhane MA, Goff DC

Schizophrenia research.. 2007 May 92 (1-3):90-4. Epub 02/23/2007.

Hepatitis C in schizophrenia: screening experience in a community-dwelling clozapine cohort.

Freudenreich O, Gandhi RT, Walsh JP, Henderson DC, Goff DC

Psychosomatics.. 2007 48 (5):405-11. Epub 1900 01 01.

An Elusive Diagnosis of Vanishing Bile Duct Syndrome in an HIV Patient.

Ayyad, M; Patel R; Molnar K; and Walsh J.

Case Reports in Medicine.

Battling the Feed: How Social Media Has Overtaken Professional Medical Advice.

Ayyad, M; Walsh J.

Patient Education and Counseling. .

Books

Psychosis - From Cell to Society. (2025)

Chapter: The Role of Primary Care in Identifying Early Psychosis.

Authors: Walsh, J.P. & Walsh, B.C.

Publisher: Intechopen 2025

Ratings & Comments

At University of Rochester Medicine, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URochester Medicine partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Contact